Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL

Published:2021-02-10 Issue:4 Volume:39 Page:961-970
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Zhao Linlin,Lv Chengfang,Sun Lili,Li Qi,Wang Yuhuang,Wu Min,Wang Yuying,Guo Zhibo,Bian Sicheng,Kong Desheng,Lin Leilei,Wang Yu,Zhou Jin,Li Yinghua

Funder

Scientific Research and Innovation Fund of the First affiliated Hospital of Harbin Medical University

Foundation for the Dean of Southern University of Science and Technology Hospital in 2020

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-021-01079-5.pdf

Reference38 articles.

1. Malouf C, Ottersbach K (2017) Molecular processes involved in B cell acute lymphoblastic leukaemia. Cell Mol Life Sci 75:417–446. https://doi.org/10.1007/s00018-017-2620-z

2. Ciprian T, Shigeo F, Cristian B, Onaciu A, Chira S, Petrushev B, Micu WT, Moisoiu V, Osan C, Constantinescu C, Pasca S, Jurj A, Pop L, Berindan-Neagoe I, Dima D, Kitano S (2018) Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia. Front Immunol 9:239–251. https://doi.org/10.3389/fimmu.2018.00239

3. Paul S, Kantarjian H, Jabbour EJ (2016) Adult acute lymphoblastic leukemia. Mayo Clin Proc 91:1645–1666. https://doi.org/10.1016/j.mayocp.2016.09.010

4. Ustwani OA, Gupta N, Bakhribah H, Griffiths EA, Wang ES, Wetzler M (2015) Clinical updates in adult acute lymphoblastic leukemia. Crit Rev Oncol Hematol 99:189–199. https://doi.org/10.1016/j.critrevonc.2015.12.007

5. Frey NV, Luger SM (2015) How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Blood 126:589–596. https://doi.org/10.1182/blood-2014-09-551937

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells;Cancer Communications;2024-05-07

2. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax;Clinical Epigenetics;2024-03-26

3. Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?;European Journal of Medicinal Chemistry;2023-10

4. Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study;Hematology;2023-06-06

5. Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo;The International Journal of Biochemistry & Cell Biology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3